Covered recipient · General Payments record
JORDAN RENTZ BARHAM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$4,301.33
- Reported across 285 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $496.97 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $269.33 | 13 |
| ARGENX US, INC. | $30.76 | 1 |
| Neurocrine BioSciences, Inc. | $25.89 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.01 | 1 |
| Kyowa Kirin, Inc. | $20.51 | 1 |
| Acerta Pharma LLC | $19.90 | 1 |
| Teva Pharmaceuticals USA, Inc. | $18.72 | 1 |
| UCB, Inc. | $16.08 | 1 |
| Genentech USA, Inc. | $16.07 | 1 |
| Amgen Inc. | $15.06 | 1 |
| Galderma Laboratories, L.P. | $14.30 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.17 | 1 |
| Lilly USA, LLC | $13.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.03 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483046 | CMS |
| ABBVIE INC. | $92.07 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483048 | CMS |
| ABBVIE INC. | $23.09 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483050 | CMS |
| ABBVIE INC. | $16.14 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483052 | CMS |
| ABBVIE INC. | $16.99 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483054 | CMS |
| ABBVIE INC. | $19.66 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483056 | CMS |
| ABBVIE INC. | $14.35 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483058 | CMS |
| ABBVIE INC. | $1.71 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483060 | CMS |
| ABBVIE INC. | $29.49 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483062 | CMS |
| ABBVIE INC. | $8.44 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483064 | CMS |
| ABBVIE INC. | $12.46 | 07/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483066 | CMS |
| ABBVIE INC. | $17.50 | 07/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483068 | CMS |
| ABBVIE INC. | $12.40 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106483070 | CMS |
| Amgen Inc. | $15.06 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117197785 | CMS |
| ARGENX US, INC. | $30.76 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142144415 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.90 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104229645 | CMS |
| Galderma Laboratories, L.P. | $14.30 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145341150 | CMS |
| Genentech USA, Inc. | $16.07 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133165482 | CMS |
| Kyowa Kirin, Inc. | $20.51 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127051323 | CMS |
| Lilly USA, LLC | $13.17 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135728959 | CMS |
| Neurocrine Biosciences, Inc. | $25.89 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150951953 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.17 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119021694 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.01 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137710619 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.72 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151534075 | CMS |
| UCB, Inc. | $16.08 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143016182 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.